
Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson's Disease
Keywords: 5-HT; serotonin, 6-OHDA, 6-hydroxydopamine; CDNF; cerebral dopamine neurotrophic factor; DA; dopamine; DBS; deep brain stimulation; DOPAC; 3,4-dihydroxyphenylacetic acid; GDNF; glial cell line-derived neurotrophic factor; HVA; homovanillic acid; IBOT; ibo